Physician

Jinsong Zhang, M.D.

According to 2025 Medicare claims, Jinsong Zhang, M.D. (NPI: 1215196027) practices rheumatology in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is INFUSION SOLUTIONS OF DELAWARE (NPI: 1073614103; TIN: 010863383) and primary practice location at 19904-3309.

Zhang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 899 traditional Medicare patients, billed 360,997 HCPCS/CPT codes, and received $5,140,519 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,713 prescription claims across 484 beneficiaries totaling $2,168,481 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 91 records totaling $1,932. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $817,515 to $5,140,519. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $407,210 to $2,168,481. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.1M2015 Medicare payment: $817,515 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,066,099 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,709,922 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,709,423 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,209,390 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,436,387 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,647,049 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,718,612 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,014,281 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,140,519 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201544458,201$817,515
201649773,627$1,066,099
201753998,812$1,709,922
201864798,680$1,709,423
2019650127,146$2,209,390
2020593153,555$2,436,387
2021636166,309$2,647,049
2022951254,307$3,718,612
2023947357,496$5,014,281
2024899360,997$5,140,519

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $407,210 (USD; Tot_Drug_Cst)2016 Drug cost: $598,205 (USD; Tot_Drug_Cst)2017 Drug cost: $970,298 (USD; Tot_Drug_Cst)2018 Drug cost: $1,331,056 (USD; Tot_Drug_Cst)2019 Drug cost: $826,117 (USD; Tot_Drug_Cst)2020 Drug cost: $862,686 (USD; Tot_Drug_Cst)2021 Drug cost: $1,046,839 (USD; Tot_Drug_Cst)2022 Drug cost: $1,778,673 (USD; Tot_Drug_Cst)2023 Drug cost: $1,554,749 (USD; Tot_Drug_Cst)2024 Drug cost: $2,168,481 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152201,272$407,210
20162231,315$598,205
20172551,470$970,298
20183031,661$1,331,056
20193001,511$826,117
20202631,480$862,686
20212581,526$1,046,839
20225802,923$1,778,673
20234522,650$1,554,749
20244842,713$2,168,481

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less107519$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more468751$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more157169$66
J0897Injection, denosumab, 1 mg32330,720$20
96372Injection of drug or substance under skin or into muscle383642$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab301,540$365,392
Enbrel SureclickEtanercept181,028$252,760
EnbrelEtanercept11924$242,884
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5014344$185,007
TeriparatideTeriparatide281,232$106,656

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.91$1,932UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jinsong Zhang, M.D.?

Tedicare shows public-source Medicare data for Jinsong Zhang, M.D. (NPI 1215196027), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jinsong Zhang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jinsong Zhang, M.D.?

Jinsong Zhang, M.D. is linked to INFUSION SOLUTIONS OF DELAWARE (billing NPI 1073614103) in the available physician profile data.

Does Jinsong Zhang, M.D. have Open Payments data?

Jinsong Zhang, M.D. has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.